| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A J Thomas, M Hendriksen, M Piggott, I N Ferrier, E Perry, P Ince, J T O'Brie. A study of the serotonin transporter in the prefrontal cortex in late-life depression and Alzheimer's disease with and without depression. Neuropathology and applied neurobiology. vol 32. issue 3. 2006-07-05. PMID:16640648. |
a study of the serotonin transporter in the prefrontal cortex in late-life depression and alzheimer's disease with and without depression. |
2006-07-05 |
2023-08-12 |
human |
| A J Thomas, M Hendriksen, M Piggott, I N Ferrier, E Perry, P Ince, J T O'Brie. A study of the serotonin transporter in the prefrontal cortex in late-life depression and Alzheimer's disease with and without depression. Neuropathology and applied neurobiology. vol 32. issue 3. 2006-07-05. PMID:16640648. |
previous studies investigating the serotonin transporter (sert) in depression have been inconsistent and included a large proportion of subjects who had committed suicide. |
2006-07-05 |
2023-08-12 |
human |
| Shih-Jen Tsa. Deltamethrin, a pyrethroid insecticide, could be a potential antidepressant agent. Medical hypotheses. vol 66. issue 3. 2006-06-22. PMID:16310970. |
antidepressants, including tricyclic antidepressants, monoamine oxidase inhibitors, selective serotonin reuptake inhibitors and serotonin-noradrenalin reuptake inhibitors, are the main biological treatment for major depression. |
2006-06-22 |
2023-08-12 |
Not clear |
| Marat G Uzbekov, Eduard Y Misionzhnik, Natella M Maximova, Olga P Vertogradov. Biochemical profile in patients with anxious depression under the treatment with serotonergic antidepressants with different mechanisms of action. Human psychopharmacology. vol 21. issue 2. 2006-06-22. PMID:16342231. |
the aim of this study was to compare the biochemical profiles in patients with anxious depression under the treatment with tianeptine, a serotonin reuptake enhancer, and sertraline, a selective serotonin reuptake inhibitor. |
2006-06-22 |
2023-08-12 |
Not clear |
| Kathrin Ritter, C H Lammer. [Nacissistic personality disorder]. MMW Fortschritte der Medizin. vol 148. issue 8. 2006-06-21. PMID:16566103. |
impulsive and aggressive behavior and attacks of depression may be reduced through the use of selective serotonin reuptake inhibitors. |
2006-06-21 |
2023-08-12 |
Not clear |
| Lise Gormsen, Troels Staehelin Jensen, Flemming Winther Bach, Raben Rosenber. [Pain and depression]. Ugeskrift for laeger. vol 168. issue 20. 2006-06-21. PMID:16768896. |
possible mechanisms underlying the pathophysiology of depression and pain could be involvement of the monoamines (5-ht and na) and the hpa axis. |
2006-06-21 |
2023-08-12 |
Not clear |
| Henrik Amtoft Neubauer, Carsten Gram Hansen, Ove Wibor. Dissection of an allosteric mechanism on the serotonin transporter: a cross-species study. Molecular pharmacology. vol 69. issue 4. 2006-06-19. PMID:16434615. |
the serotonin transporter (sert), which belongs to a family of sodium/chloride-dependent transporters, is the major pharmacological target in the treatment of several clinical disorders, including depression and anxiety. |
2006-06-19 |
2023-08-12 |
human |
| Marek Lommatzsch, Katharina Hornych, Christiana Zingler, Peter Schuff-Werner, Jacqueline Höppner, J Christian Vircho. Maternal serum concentrations of BDNF and depression in the perinatal period. Psychoneuroendocrinology. vol 31. issue 3. 2006-06-08. PMID:16289360. |
there was a trend to a decrease of bdnf and 5-ht levels in cases of maternal depression (as compared to cases without depression), but this was not significant. |
2006-06-08 |
2023-08-12 |
human |
| Russel S Falck, Jichuan Wang, Robert G Carlson, Harvey A Siega. Prevalence and correlates of current depressive symptomatology among a community sample of MDMA users in Ohio. Addictive behaviors. vol 31. issue 1. 2006-06-05. PMID:15922511. |
research suggests that mdma can cause serotonin depletion as well as serotonergic neurodegradation that may result in depression among users of the drug. |
2006-06-05 |
2023-08-12 |
human |
| Jeffrey R Lacass. Consumer advertising of psychiatric medications biases the public against nonpharmacological treatment. Ethical human psychology and psychiatry. vol 7. issue 3. 2006-06-05. PMID:16604742. |
advertisements for selective serotonin reuptake inhibitors frequently contain information inconsistent with the scientific evidence on the treatment of depression with antidepressants. |
2006-06-05 |
2023-08-12 |
Not clear |
| Ying Liu, Shoji Nakamur. Stress-induced plasticity of monoamine axons. Frontiers in bioscience : a journal and virtual library. vol 11. 2006-06-02. PMID:16368556. |
this review describes the differential features of axonal plasticity of 5-ht and na neurons in relation to stress, and discusses the possible roles that the morphological plasticity of 5-ht and na axons may play in the pathophysiology of depression. |
2006-06-02 |
2023-08-12 |
Not clear |
| Shu Hasegawa, Kyoko Nishi, Arata Watanabe, David H Overstreet, Mirko Diksi. Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study. Neurochemistry international. vol 48. issue 5. 2006-06-01. PMID:16427159. |
brain 5-ht synthesis in the flinders sensitive line rat model of depression: an autoradiographic study. |
2006-06-01 |
2023-08-12 |
rat |
| Shu Hasegawa, Kyoko Nishi, Arata Watanabe, David H Overstreet, Mirko Diksi. Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study. Neurochemistry international. vol 48. issue 5. 2006-06-01. PMID:16427159. |
alterations of serotonin (5-ht) levels and serotonergic transmission have been associated with depression. |
2006-06-01 |
2023-08-12 |
rat |
| Shu Hasegawa, Kyoko Nishi, Arata Watanabe, David H Overstreet, Mirko Diksi. Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study. Neurochemistry international. vol 48. issue 5. 2006-06-01. PMID:16427159. |
5-ht synthesis is an important factor of serotonergic neurotransmission that may also be altered in depression. |
2006-06-01 |
2023-08-12 |
rat |
| Arata Watanabe, Shu Hasegawa, Kyoko Nishi, Khnah Q Nguyen, Mirko Diksi. Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study. Brain research bulletin. vol 69. issue 2. 2006-06-01. PMID:16533657. |
furthermore, our results support the hypothesis that 5-ht1a receptors mediate the antidepressant-like effect of 5-ht1a agonists, as the chronic 5-ht1a agonist treatment in the depression model known to be sensitive to antidepressants resulted in the normalization of 5-ht synthesis. |
2006-06-01 |
2023-08-12 |
rat |
| Donald Han, Edward C Y Wan. Remission from depression : a review of venlafaxine clinical and economic evidence. PharmacoEconomics. vol 23. issue 6. 2006-05-30. PMID:15960553. |
in 2000, depression cost the us more than us 83 billion dollars annually in lost productivity, medical expenses and premature death.venlafaxine, a dual-acting serotonin norepinephrine (noradrenaline) reuptake inhibitor, may improve a patient's response to treatment and their chances of achieving complete remission compared with conventional antidepressant therapies, with the evidence for this being the strongest for comparisons with the selective serotonin receptor inhibitors (ssris). |
2006-05-30 |
2023-08-12 |
Not clear |
| Rajamannar Ramasubbu, Rose Tobias, Alastair M Buchan, N Torben Bech-Hanse. Serotonin transporter gene promoter region polymorphism associated with poststroke major depression. The Journal of neuropsychiatry and clinical neurosciences. vol 18. issue 1. 2006-05-26. PMID:16525076. |
serotonin transporter gene promoter region polymorphism associated with poststroke major depression. |
2006-05-26 |
2023-08-12 |
human |
| Rajamannar Ramasubbu, Rose Tobias, Alastair M Buchan, N Torben Bech-Hanse. Serotonin transporter gene promoter region polymorphism associated with poststroke major depression. The Journal of neuropsychiatry and clinical neurosciences. vol 18. issue 1. 2006-05-26. PMID:16525076. |
the authors examined variations of serotonin transporter-linked promoter region (5-httlpr) functional polymorphism in 26 stroke patients with major depression and in 25 unrelated nondepressed stroke subjects of caucasian descent. |
2006-05-26 |
2023-08-12 |
human |
| Martijn Meeter, Lucia Talamini, Jeroen A J Schmitt, Wim J Riede. Effects of 5-HT on memory and the hippocampus: model and data. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 31. issue 4. 2006-05-25. PMID:16132065. |
5-hydroxytryptamine (5-ht) transmission has been implicated in memory and in depression. |
2006-05-25 |
2023-08-12 |
human |
| Martijn Meeter, Lucia Talamini, Jeroen A J Schmitt, Wim J Riede. Effects of 5-HT on memory and the hippocampus: model and data. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 31. issue 4. 2006-05-25. PMID:16132065. |
both 5-ht depletion and specific 5-ht agonists lower memory performance, while depression is also associated with memory deficits. |
2006-05-25 |
2023-08-12 |
human |